wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47134049-3ABFFD40-18EC-4094-8E41-99CDEA09C537
Q47134049-3ABFFD40-18EC-4094-8E41-99CDEA09C537
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47134049-3ABFFD40-18EC-4094-8E41-99CDEA09C537
Survivin: A novel marker and potential therapeutic target for human angiosarcoma.
P2860
Q47134049-3ABFFD40-18EC-4094-8E41-99CDEA09C537
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47134049-3ABFFD40-18EC-4094-8E41-99CDEA09C537
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aa45817dc7dec906cca41276fc94a4be8c5544aa
P2860
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.